Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
Sonia HaribhaiNehaa KhadkaRufaro MvududuNyiko MasheleLinda-Gail BekkerPamina GorbachThomas J CoatesLandon MyerDvora Joseph DaveyPublished in: International journal of STD & AIDS (2023)
PrEP-focused healthcare access pathways for pregnant and postpartum AGYW need to be simplified. Further research is needed on health system determinants (i.e., structural barriers, provider-client interactions, and related outcomes) of oral PrEP utilization. In 2022, South Africa announced regulatory approval of long-acting PrEP options (i.e., the dapivirine ring for non-pregnant women and injectable cabotegravir, respectively); these may mitigate implementation barriers reported in this study. However, the safety and efficacy of long-acting PrEP (e.g., injectables, implants) among pregnant or breastfeeding women, specifically, remains to be confirmed in this setting.
Keyphrases
- south africa
- pregnant women
- men who have sex with men
- hiv positive
- healthcare
- primary care
- pregnancy outcomes
- mental health
- polycystic ovary syndrome
- transcription factor
- preterm infants
- adipose tissue
- type diabetes
- insulin resistance
- hyaluronic acid
- hiv infected
- tissue engineering
- human immunodeficiency virus
- hepatitis c virus
- breast cancer risk
- drug administration